Dheepa Chari joins EMJ GOLD to discuss her career path, AI in pharma and the future of scientific communication.

Look back on Season 9’s GOLD Medal Moments with the team before Season 10 begins.

Dr Dennise Broderick, President and Managing Director, Galen Pharma joins the GOLD podcast to discuss her life-long ambition to be a leader and how she approaches hard decisions in business. 

How can pharma navigate setbacks in drug development to deliver breakthroughs in R&D? Find out from Christoph von der Goltz, Boehringer.

Rebecca Vermeulen, recipient of the HBA STAR award for 2025 joins the podcast to discuss what effective patient centricity looks like and more.

In this episode, uncover how AI is shaking up the radiology space with Naiara Martínez Cabrera, Vice President, Global Marketing, DeepHealth. 

Discover what’s on the horizon for cardiac care and remote monitoring with Angelo Auricchio, Chief Medical Officer, Rhythm Management, Boston Scientific.

Mary Stutts, CEO, HBA, unpacks the key findings of a report exposing critical gaps in doctors’ understanding of women’s health.

Explore the science behind memory, recall and retention, and uncover why interactive content could be the future in this podcast.

Uncover more of Martin Price, Vice President, Health Economics, Market Access and Reimbursement, EMEA, Johnson & Johnson’s thoughts on the oncology space

A World Cancer Day edition of the podcast, with Martin Price, Vice President, Health Economics, Market Access and Reimbursement, EMEA, J&J.

The team are joined by Charl van Zyl, President and CEO, Lundbeck Pharmaceuticals, to discuss advances in the treatment of neurological disorders.

Curious to know could happen in the industry in 2025? Join us as we talk to three guests about their top predictions for the year ahead.

Look back at the key moments from the past year in pharma with three of our former guests, as they highlight key trends, challenges and more.

Find out how to normalise the conversation, not the suffering, around menopause with Dr Cecilia Caetano, Vice President, Women’s Health, Bayer.

Season 8 is almost over, but before we release our finale episode, why not take a listen to some of our favourite moments from the series just gone?

Elias Revonta, Founder & CEO, Orcason Medical, joins the podcast to discuss why the fight against AMR needs to extend beyond awareness weeks.

Patrick Oliver, General Manager for the UK and Ireland at Alfasigma explores the company’s exciting entry into the UK market and the evolving healthcare landscape in the country.

Join Jade and Isabel as they explore the critical trends that have shaped the industry in 2024 and what teams should leverage in Q4.

Jennifer Schranz, SVP and Global Head of Rare Diseases, Ipsen, joins the podcast to discuss the burden faced by women with rare diseases.

Richard Lowenthal, CEO, ARS Pharmaceuticals, reveals the company’s mission to address unmet needs in allergy care with its new nasal spray.

Martina Dempsey, VP of Commercial Strategy and Operations at Astellas Europe, discusses empowering women in the pharmaceutical industry.

Nedim Pipic, Senior Vice President and Global Therapeutic Area Head for Mental Health, Boehringer Ingelheim marks World Mental Health Day.

Join JB, ViiV Healthcare Europe to explore the HIV landscape in Europe, the UNAIDS plan to end the epidemic by 2030 and more in this podcast.